Neuroprotective Effects of Herbal Ethanol Extracts from Gynostemma pentaphyllum in the 6-Hydroxydopamine-Lesioned Rat Model of Parkinson's Disease

被引:50
|
作者
Choi, Hyun Sook [1 ,2 ]
Park, Mi Sook [1 ,2 ]
Kim, Seung Hwan [3 ]
Hwang, Bang Yeon [1 ,2 ]
Lee, Chong Kil [1 ,2 ]
Lee, Myung Koo [1 ,2 ]
机构
[1] Chungbuk Natl Univ, Coll Pharm, Cheongju 361763, South Korea
[2] Chungbuk Natl Univ, Res Ctr Bioresource & Hlth, Cheongju 361763, South Korea
[3] Kyung Hee Univ, Coll Phys Educ, Yongin 449701, South Korea
来源
MOLECULES | 2010年 / 15卷 / 04期
关键词
Gynostemma pentaphyllum; 6-hydroxydopamine-lesioned rats; tyrosine hydroxylase; dopamine; Parkinson's disease; L-DOPA; CUCURBITACEAE PLANTS; SAPONIN CONSTITUENTS; BRAIN; 6-OHDA; CELLS; IRON;
D O I
10.3390/molecules15042814
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
6-Hydroxydopamine administration for 28 days (8 mu g/2 mu L) reduced the number of tyrosine hydroxylase (TH)-immunopositive neurons to 40.2% in the substantia nigra compared to the intact contralateral side. Dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid and norepinephrine levels were reduced to 19.1%, 52.3%, 47.1% and 67.4% in the striatum of 6-hydroxydopamine-lesioned rats compared to the control group, respectively. However, an oral administration of herbal ethanol extracts from Gynostemma pentaphyllum (GP-EX) (10 mg/kg and 30 mg/kg) starting on day 3 post-lesion for 28 days markedly ameliorated the reduction of TH-immunopositive neurons induced by 6-hydroxydopamine-lesioned rat brain from 40.2% to 67.4% and 75.8% in the substantia nigra. GP-EX administration (10 and 30 mg/kg) also recovered the levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid and norepinephrine in post-lesion striatum to 64.1% and 65.0%, 77.9% and 89.7%, 82.6% and 90.2%, and 88.1% and 89.2% of the control group. GP-EX at the given doses did not produce any sign of toxicity such as weight loss, diarrhea and vomiting in rats during the 28 day treatment period and four gypenoside derivatives, gynosaponin TN-1, gynosaponin TN-2, gypenoside XLV and gypenoside LXXIV were identified from GP-EX. These results suggest that GP-EX might be helpful in the prevention of Parkinson's disease.
引用
收藏
页码:2814 / 2824
页数:11
相关论文
共 50 条
  • [21] Flibanserin attenuates L-DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson's disease
    Gerlach, Manfred
    Beck, Juergen
    Riederer, Peter
    van den Buuse, Maarten
    JOURNAL OF NEURAL TRANSMISSION, 2011, 118 (12) : 1727 - 1732
  • [22] Protective effects of Hibiscus sabdariffa extracts in 6-hydroxydopamine-lesioned parkinsonism.
    Hamadjida, A.
    Otto, G. Ndji
    Kilekoung, M. K. Mingoas
    MOVEMENT DISORDERS, 2022, 37 : S312 - S313
  • [23] Neuroprotective effects of nicotine in a 6-hydroxydopamine model of Parkinson's disease
    Minamino, Hideaki
    Yanagida, Takashi
    Kitamura, Yoshihisa
    Taniguchi, Takashi
    Shimohama, Shun
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 227P - 227P
  • [24] Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease
    Henry, B
    Crossman, AR
    Brotchie, JM
    EXPERIMENTAL NEUROLOGY, 1998, 151 (02) : 334 - 342
  • [25] Optogenetic Globus Pallidus Stimulation Improves Motor Deficits in 6-Hydroxydopamine-Lesioned Mouse Model of Parkinson's Disease
    Caballero, Sonia Di Bisceglie
    Ces, Aurelia
    Liberge, Martine
    Ambroggi, Frederic
    Amalric, Marianne
    Ouagazzal, Abdel-Mouttalib
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [26] Entacapone increases and prolongs the central effects of levodopa in the 6-hydroxydopamine-lesioned rat
    Gerlach, M
    van den Buuse, M
    Blaha, C
    Bremen, D
    Riederer, P
    MOVEMENT DISORDERS, 2005, 20 : S100 - S100
  • [27] Behavioral effects of 5-HT2C receptor antagonism in the substantia nigra zona reticulata of the 6-hydroxydopamine-lesioned rat model of Parkinson's disease
    Fox, SH
    Moser, B
    Brotchie, JM
    EXPERIMENTAL NEUROLOGY, 1998, 151 (01) : 35 - 49
  • [28] Neuroprotection in a 6-hydroxydopamine-lesioned Parkinson model using lactoferrin-modified nanoparticles
    Huang, Rongqin
    Han, Liang
    Li, Jianhua
    Ren, Feiliang
    Ke, Weilun
    Jiang, Chen
    Pei, Yuanying
    JOURNAL OF GENE MEDICINE, 2009, 11 (09): : 754 - 763
  • [29] Effects of subthalamic nucleus lesions and stimulation upon corticostriatalafferents in the 6-hydroxydopamine-lesioned rat
    Walker, R. H.
    Moore, C.
    Davies, G.
    Dirling, L.
    Kock, R. J.
    Meshul, C. K.
    MOVEMENT DISORDERS, 2012, 27 : S171 - S171
  • [30] Effect of Chronic Administration of Ferulic Acid in 6-Hydroxydopamine Lesioned Rat's Model of Parkinson's Disease
    Khawade, Ajinkya
    More, Ganesh
    Aswar, Urmila
    Aswar, Manoj
    INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 : S247 - S247